Saif, Muhammad. “U.S. Food and Drug Administration Approves Paclitaxel Protein-Bound Particles (Abraxane®) in Combination With Gemcitabine As First-Line Treatment of Patients With Metastatic Pancreatic Cancer”. JOP. Journal of the Pancreas 14, no. 6 (November 10, 2013): 686-688. Accessed May 19, 2024. http://www.serena.unina.it/index.php/jop/article/view/2028.